Industry Priorities in Puerto Rico: The Path Forward
Despite being a small island in the Caribbean, measuring just 100 by 35 miles, Puerto Rico has long punched above its weight as an industrial powerhouse. Already a leading producer…
Already a solid hub for biopharma manufacturing and logistics, Puerto Rico is moving to sharpen its position in the evolving US reshoring landscape and attract new investment. Under the banner “Made in Puerto Rico is Made in the USA,” Governor…
Despite being a small island in the Caribbean, measuring just 100 by 35 miles, Puerto Rico has long punched above its weight as an industrial powerhouse. Already a leading producer…
Long celebrated for its world-class pharmaceutical and medical device manufacturing, Puerto Rico is now leveraging this strong foundation to nurture a new era of research and development. Rather than shifting…
With over 80,000 people directly and indirectly employed in Puerto Rico’s biosciences sector, the island relies heavily on a skilled and stable workforce to maintain its competitive edge. But it…
Ivan Lugo, executive director at Puerto Rico’s Industry University Research Center, Inc. (INDUNIV) with over 40 years of global pharmaceutical expertise, explains how his not-for-profit organization promotes Puerto Rico’s competitiveness…
Carlos Rodríguez, the newly elected president of the Puerto Rico Manufacturers Association (PRMA), underlines his main goal of achieving more collaboration within the association and the economic ecosystem, to facilitate…
Rayne Waller, VP Manufacturing for Amgen Manufacturing Limited in Puerto Rico, is leading the operations at the company’s largest manufacturing facility in Juncos, which manufactures more than 90 percent of…
The largest pharmaceutical hub in the Americas, Puerto Rico currently exports to 120 countries, accounting for nearly USD 53 billion in weekly biopharma shipments. Remarkably, this small Caribbean island out-exports all…
Across over 50 interviews with Puerto Rican government and industry stakeholders, energy supply was continuously identified as the main barrier to growth. Puerto Rico’s ageing, centralised, and fossil fuel–dependent power…
Puerto Rico’s healthcare system is a paradox of strength and fragility. With one of the highest insurance coverage rates in the US (around 94 percent) and a long tradition of…
Can Puerto Rico capitalise on the Trump administration’s “make in America” push? President Donald Trump wants to bring manufacturing back to America. The last 40 years of globalisation and…
Spending almost 30 years working for a single company is almost unheard of in today’s life science industry, where executives chop and change between firms with bewildering frequency. However,…
In cell and gene therapy, where R&D and manufacturing are inseparable, Puerto Rico’s strong biopharma base makes it an attractive option for CGT companies. The first mover in this…
See our Cookie Privacy Policy Here
